Horizon Technology Finance Corporation Provides $45MM Term Loan to Evelo Biosciences
Evelo Biosciences, a clinical stage biotechnology company, entered into a senior secured loan agreement with Horizon Technology Finance Corporation. The $45 million term loan replaces the company’s existing senior secured debt.